Goodwin Guides Deep Apple Therapeutics in Collaboration with Novo Nordisk to Discover and Develop Oral Therapeutics for Cardiometabolic Diseases for up to $812 Million

Goodwin Procter acted for Deep Apple Therapeutics in a research collaboration and exclusive worldwide license agreement with Novo Nordisk to discover, develop, and commercialize oral small molecule therapeutics directed at a novel non-incretin GPCR target for cardiometabolic diseases.

Read More

Rivian Completes Refinancing

Simpson Thacher & Bartlett acted for the initial purchasers, led by J.P. Morgan Securities LLC, in the Rule 144A/Regulation S offering by Rivian Holdings, LLC, Rivian, LLC and Rivian Automotive, LLC of $1.25 billion aggregate principal amount of 10.000% Senior Secured Green Notes due 2031.

Read More

Ford Foundation Invests in Nine Dean

Simpson Thacher acted for the Ford Foundation in its investment in Nine Dean that will allow it to officially launch with an experienced team with the goal of acquiring middle-market businesses with the goal of stewarding them toward operational success.

Read More

Crowell & Moring expands London presence

Crowell & Moring expands its London office footprint significantly to over 14,000 square feet at its newly renovated space located at 199 Bishopsgate.

Read More

Aggreko’s $1.4 Billion and €850 Million High‑Yield Senior Secured Notes Offering and $1.195 Billion Revolving Credit Facility

Cravath, Swaine & Moore LLP acted for the initial purchasers in the $1.4 billion and €850 million Rule 144A/Reg. S high yield senior secured notes offering of Albion Financing 1 S.à r.l and Aggreko Holdings Inc. for the purpose of repaying all of Aggreko’s outstanding senior secured notes and senior notes, paying a dividend and…

Read More